Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by skier59on Apr 03, 2021 8:07pm
219 Views
Post# 32934460

RE:25% plus of company

RE:25% plus of companyOk I felt I should chime in 1 last time. So, a valid question from Tina-TNA or whomever you are???

So they have 5000 Patients being treated for Cancer......DUH...if I had CANCER I would want to be checked on a very regular basis, even annually. This is a no Brainer ! Also helps develop a more internal critical study program, which can only help us long into the future, not relying on external data which can be ......let's say kind of flucked up ! I don't think many understand how this Partnership can help develop the critical data required to push Aristotle as a well known test, long into the future.

I'm a Marketing guy, and I like the "Name" of the Company we will aquire. Strong Title of a name can help develop a Company for great things in the future, providing one has a strong business plan, and an experienced knowledgeable Management Team. Remember, APPLE was a penny stock and laughed at for many many years.

Don't be a fool or sucker, hold your Shares and forget about them. Never bet the house. Give the Business Plan time to evolve. Our new Partners will also want to see their Shares in SZLS go way the fluck up....so don't get scared, as I've told my Buddies having a position. Block out the noise, let the Day-Traders have their fun, as we have experienced, and believe in the Product.




LionWhisperer wrote: Is being offered for these clinics when you add up the shares they will use to buy it.I want to know what we get for 20 miullion dolars of SZLS stock....Like is there even any bricks and mortar assest or just some rented space in a couple cities with few offices.Goodwill has value but one has to make sure its paybacks will essentially pay for the acquisition in the future


<< Previous
Bullboard Posts
Next >>